PharmaVentures Monthly Podcast Series

Review of 2022: M&A, Licensing and Fundraising

Listen as Fintan Walton, PharmaVentures’ CEO and Founder, reflects on this year’s deal trends in M&A, Licensing and Fundraising, considers the significant macroeconomic events, and offers insight into what impact they may have on the global pharma and biotech industry in 2023.